Status:

ENROLLING_BY_INVITATION

Prediction of Hyperperfusion After Carotid Stenting by Multi-parameter Characteristics Based on Cerebral Autoregulation

Lead Sponsor:

Xuanwu Hospital, Beijing

Conditions:

Cerebral Artery Stenosis

Carotid Artery Stent

Eligibility:

All Genders

18-80 years

Brief Summary

Cerebral hyperperfusion syndrome (CHS) is one of the severe complication after carotid artery stenting with a high mortality rate. CHS was defined as cerebral hyperperfusion (CH) with clinical symptom...

Detailed Description

1. To analysis the incidence of postoperative complications such as CH and CHS within 1 months and to find the risk factors of CH. A. To enroll 400 cases of patients suffering from carotid artery ...

Eligibility Criteria

Inclusion

  • (1) Male and non-pregnant, non-breastfeeding female subjects whose age is ≥ 18 years and ≤ 80.
  • (2) Symptomatic patients with internal carotid artery stenosis≥50% on angiography, or asymptomatic patients with internal carotid artery stenosis≥70% on angiography treatable with carotid artery stenting.
  • (3) Patient is willing and capable of complying with all study protocol requirements, including the specified follow-up visits and can be contacted by telephone.

Exclusion

  • (1) Patients with severe carotid artery stenosis caused by non-atherosclerosis diseases, such as dissection or arteritis.
  • (2) Inability to cooperate with all this examination.
  • (3) Patients without complete clinical or imaging information.
  • (4) Patients not evaluated by CDU before CAS or within 1 week after CAS.
  • (5) Lack of follow up with CDU after CAS.
  • (6) Patients with poor temporal sound window or closure of the temporal window.
  • (7) Hyperthyroidism, hemicrania, severe arrhythmia and other diseases affecting dCA.

Key Trial Info

Start Date :

September 1 2023

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

September 1 2026

Estimated Enrollment :

400 Patients enrolled

Trial Details

Trial ID

NCT06058676

Start Date

September 1 2023

End Date

September 1 2026

Last Update

September 28 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Department of Vascular Ultrasonography, Xuanwu Hospital of Capital Medical University

Beijing, Beijing Municipality, China, 100053